Traduction de «dossier d'évaluation du programme cap » (Français → Anglais) :

Question No. 83 Mr. Rodger Cuzner: With regard to participation by the government through the Enterprise Cape Breton Corporation (ECBC) in the sponsoring of a yacht in the Clipper 09-10 Round the World Yacht Race (Sponsorship Program): (a) what was the total overall budgeted cost of the Sponsorship Program, broken down by cost category including all the activities associated with the sponsorship; (b) what was the total overall actual cost of the Sponsorship Program compared to the budget; (c) what was the budget and actual cost for ...[+++]each trade event associated with the Sponsorship Program; (d) how many ECBC employees attended each specific international trade or non trade event as part of the Sponsorship Program; (e) how many businesses attended each trade event associated with the Sponsorship Program; (f) what was the travel cost of ECBC employees who attended the Sponsorship Program events, broken down by each event; (g) what was the cost of subsidizing non government employees to attend international Sponsorship Program events, broken down by event; (h) what were the evaluation results from non government employees who partook in the Sponsorship Program events; (i) what evaluation metrics were put in place to determine the effectiveness of the cost of the total Sponsorship Program; and (j) what evaluation results have been received to date on the effectiveness of the Sponsorship Program?

Question No. 926 Mr. Michael Savage: With regard to possible tax evasion in Switzerland: (a) how many Canadians have been identified as having undeclared bank accounts in Switzerland; (b) what action, if any, has been taken by Canadian officials to recover unpaid taxes associated with Canadians' undeclared bank accounts in Switzerland; (c) how many identified Canadians have availed themselves of the Voluntary Disclosure Program (VDP) with the Canada Revenue Agency (CRA); (d) how many identified Canadian accounts have settled with t ...[+++]he CRA; (e) how much money has the CRA assessed as a result of investigating these secret banks accounts in Switzerland (i) in unpaid taxes, (ii) in interest, (iii) in fines, (iv) in penalties; (f) how much of the money in (e) has been collected; (g) how many of the cases are under appeal; (h) how many cases remain open; (i) how many more cases does the CRA anticipate will be opened; (j) how many cases have been closed (i.e., the full amount of taxes, interest, fines and penalties have been collected); (k) how much money in (j) has been collected (i) in unpaid taxes, (ii) in interest, (iii) in fines, (iv) in penalties; (l) how many account holders in the cases have made partial payment; (m) of the partial payments made, what was the (i) largest amount, (ii) smallest amount, (iii) average amount; (n) how much does the CRA anticipate it has yet to collect in (i) taxes, (ii) interest, (iii) fines, (iv) penalties; (o) of the amounts of money contained in the Switzerland accounts declared or discovered by CRA, what was the (i) largest amount, (ii) smallest amount, (iii) average amount; (p) on what date was the CRA first made aware of the names of Canadians with accounts in Switzerland; (q) on what date did the CRA begin its investigation; (r) on what date did the first audit of an individual account holder begin; (s) how many of the identified Canadians with bank accounts in Switzerland (i) have had their account or accounts a ...

Having regard to the conclusions of the Working Group on evaluation of solidarity dossiers, it is appropriate to extend the 2-year period for the programmes concerned, while reducing the rate of the Union financial contributions for these measures to 45 % of eligible expenditure for the third year and to 40 % for the fourth year of these programmes.

Question No. 397 Ms. Kirsty Duncan: With respect to initiatives and programs run by the Department of National Defence (DND) and Veterans Affairs Canada (VAC) in relation to veterans’ health and welfare: (a) what are the issues affecting (i) Canada’s traditional war veteran population, (ii) Canadian Forces (CF) veterans; (b) for each group of veterans in (a), how many cases were there per identified issue, per year, over the last ...[+++]five years; (c) for each group of veterans in (a), what changes have occurred in the issues over the last five years; (d) for CF veterans, what key issues are anticipated following the withdrawal from Afghanistan in 2011, and for each anticipated issue, what are the (i) challenges, (ii) changes necessary to VAC, (iii) actions taken to date; (e) what recommendations, if any, have been made to improve the quality of life for veterans identified in (a) and what steps, if any, have been taken to address these recommendations; (f) what specific measures are being taken to ensure that VAC (i) responds quickly to emerging research, such as the possible link between combat and amyotrophic lateral sclerosis, and combat and dementia, (ii) implements research recommendations in a timely manner; (g) what are the categories of injuries sustained by the Canadian troops in Afghanistan; (h) what specific rehabilitation is provided for each injury category, by region; (i) what reviews of rehabilitation procedures have been undertaken, by date and region; (j) for each injury category identified in (g), what percentage of veterans are able to return to civilian work; (k) what specific measures are undertaken by region to help veterans normalize to civilian life; (l) what specific measures are used to ensure veterans returning from Afghanistan are informed of veterans' benefits; (m) what is the process for acquiring the help of a case manager; (n) what are the specific steps a veteran needs to take following a release or a medical release in order ...

(Return tabled) Question No. 177 Mr. Peter Julian: With regard to nanotechnology: (a) what are the total federal funds spent and committed for expenditure, for each of the fiscal years from 2005-2006 through 2008-2009 inclusive, broken down by department and criterion; (b) who are the recipients of these funds; (c) to what purpose was funding for nanotechnology used by institutions and departments, including the Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research, the Canadian Foundation for Innovation, Natural Resources Canada, Industry Canada, and the National Research Council of Canada; (d) what were the amounts allocated to test health, safety, and environmental impacts of nanoproducts ...[+++]and nanomaterials; (e) what is the list of nanomaterials currently in the market; (f) which of these have been extensively tested to determine possible effects on human and environmental health and safety and, of those tested, which, if any, raised concern or required mitigation or prevention; (g) how many assessments on nanomaterial notification packages have been submitted to the New Substances Notification Program to date and (i) of these notification packages, have there been any nanomaterials rejected for entry into Canada, (ii) have there been any conditions of use placed based on assessment results and, if so, how many; (h) did the government ever request notifiers (companies or individuals) providing nanomaterial notification packages to submit additional toxicity data above and beyond what is requested in the schedules of the New Substances Notification Regulations and, if so, did this result in refusal of entry into the Canadian market or justify use of material with conditions; and (i) what information, notifications or advisories have been issued to ensure the safe discovery, production, manufacturing, use and disposal of nanomaterials and nano-enabled products, (i) when, (ii) by which departments?

Periodic meetings were organised by the Commission services (Enlargement, External Relations and Regional Policy with the experts in EC Delegations responsible for Phare and ISPA implementation to discuss programming and implementation issues, in particular related to tendering and contracting. At present - before EDIS - EC Delegations are responsible for ex-ante approval/endorsement of tender documents, evaluation committees and contracts. Communication and information